Dyne Therapeutics director Kersten sells $219k in company stock

Dyne Therapeutics director Dirk Kersten sold approximately $219,169 worth of company stock across two transactions on April 21 and 22, 2026, through a pre-arranged trading plan. Despite the sales, the company’s stock has seen an 82% return over the past year, and analysts maintain positive ratings and price targets, reflecting confidence in its clinical programs. The biotechnology firm also exhibits a strong financial position with more cash than debt and upcoming earnings on April 30.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin